The sky might be the limit for a biotech company with a pipeline candidate that beat the world's top-selling drug in a late-stage clinical study.

The clinical-stage drugmaker's cancer therapy candidate outperformed Keytruda, the world's top-selling cancer drug.

Summit Bike Share opened a new station in September near Park City Hospital. With a new station at the Park City Hospital, ...

SUMMIT COUNTY, Ohio — A 19-year-old man was fatally shot in Summit County on Sunday. According to a release, members of the Summit County Sheriff's Office responded to 2600 South Arlington Road ...

CACI International CACI shares have gained 51.5% year to date, outperforming the Zacks Computer and Technology Sector and S&P 500 index’s growth of 19.4% and 18.1%, respectively. CACI ...

“Prior to the accident, the man had been kicked out of a local business for being unruly and intoxicated,” according to a press release from the Summit County Sheriff’s Office. The incident ...

In a report released yesterday, Matthew Akers from Wells Fargo maintained a Buy rating on Caci International (CACI ... fair prices is reinforced by their recent procurement of Azure Summit ...

IT Services Provider CACI International to Buy Azure Summit Technology for $1.28 Billion (Reuters) - IT services provider CACI International said on Monday it would buy software firm Azure Summit ...

Is Summit Therapeutics a good investment now ... Instead of opening your brokerage application to buy this biotech stock at its recently inflated valuation, it may be better to watch from a ...

Shares of Summit Therapeutics (NASDAQ: SMMT) recently jumped in response to positive clinical trial results for its experimental cancer therapy. Results of the phase 3 Harmoni-2 trial suggest ...